Tharimmune, Inc. (NASDAQ:THAR) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
Tharimmune, Inc.'s stock currently trades at $3.01 with a market capitalization of $88.8M. The Healthcare company's stock moved following the disclosure.